Paliperidone is administered via intramuscular injection. Dosing varies based on the specific formulation and indication.
How is paliperidone given and what are the common doses?
The long-acting injectable formulations of paliperidone require specific dosing regimens. For schizophrenia in adults, the initial dose is typically 234 mg on day 1, followed by 156 mg one week later, and then 78 mg every four weeks. [1]
For schizoaffective disorder in adults, initial dosing can also be 234 mg on day 1, followed by 156 mg one week later, and then 78 mg every four weeks. [1]
What are the different types of paliperidone injections?
Paliperidone is available in several long-acting injectable formulations. These include the Paliperidone Palmitate (PP) extended-release injectable suspension, which is administered monthly, and a six-month extended-release injectable suspension. [2]
How often are paliperidone injections administered?
The frequency of paliperidone injections depends on the specific formulation. The monthly PP extended-release injectable suspension is administered once every four weeks. [2] The six-month extended-release injectable suspension is given twice a year. [2]
Can paliperidone dosing be adjusted?
Dosing adjustments for paliperidone are based on clinical response and tolerability. For example, if a dose increase is needed for schizophrenia or schizoaffective disorder after the initial doses, it might be adjusted to 234 mg at the first monthly injection after the loading doses, followed by 156 mg or 234 mg every four weeks. [1] Conversely, if a dose reduction is necessary, it can be lowered to 78 mg every four weeks. [1]
What are the key differences between paliperidone and risperidone dosing?
Paliperidone is the active metabolite of risperidone, meaning it is what risperidone breaks down into in the body. While risperidone is taken orally and can be injected, paliperidone is primarily available as long-acting injectables. Dosing strategies for the two drugs differ due to their pharmacokinetic profiles and available formulations. [3]
What are the risks associated with paliperidone injections?
Common risks associated with paliperidone injections include injection site reactions such as pain, redness, or swelling. [1] Other potential side effects, as with oral antipsychotics, can include movement disorders (extrapyramidal symptoms), weight gain, and hormonal changes. [4] Serious adverse events like neuroleptic malignant syndrome are rare but possible. [1]
When does paliperidone patent expiry occur?
Information on specific patent expiry dates for paliperidone formulations is available from resources like DrugPatentWatch.com. These dates can vary depending on the specific patent and formulation. [5]
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021927s035,022544s017,026401s011lbl.pdf
[2] https://www.drugpatentwatch.com/drug/paliperidone-palmitate
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744134/
[4] https://www.mayoclinic.org/drugs-supplements/paliperidone-oral-route-injection-route/side-effects/drh-20069171
[5] https://www.drugpatentwatch.com/drugs/paliperidone